Discovery of non-glucoside SGLT2 inhibitors |
| |
Authors: | Li An-Rong Zhang Jian Greenberg Joanne Lee TaeWeon Liu Jiwen |
| |
Institution: | Amgen Inc., 1120 Veterans Boulevard, South San Francisco, CA 94080, USA |
| |
Abstract: | A series of benzothiazinone and benzooxazinone derivatives were discovered as SGLT2 inhibitors. The optimization led to the discovery of compounds 31 and 32, which exhibited similar potency and better SGLT1 selectivity compared to dapagliflozin. These compounds may provide novel promising scaffolds, which are different from phlorizin-based SGLT2 inhibitors. |
| |
Keywords: | Non-glucoside SGLT2 Inhibitor Glucose Diabetes |
本文献已被 ScienceDirect PubMed 等数据库收录! |